Eric Lefkofsky is known for his business ventures. These include InnerWorkings as well as Echo Global Logistics besides Groupon.He has earned over $1.79 billion with his e-commerce startups. But he is not resting on his laurels here. He is poised for doing bigger as well as better things. His latest company is called Tempus. It has a huge goal of assembling a genomic database for cancer. This is a humongous exercise. With this database, the doctors will be able to compare the DNA of their patients so that their therapies can be customized. Hence doctors will be able to help their patients suffering from cancer to live much longer. Besides, this will also help to cure many people.
Eric Lefkofsky is well aware that technology is moving at a very high pace. He also realized that it was not moving at the same speed in the medical arena. This is because even though physicians were collecting a large amount of their patients’ data, they were lacking any means for analyzing it.There are many startups along with non-profits that are looking for the best ways for treating diseases. This would require performing several genetic screening tests besides storing the data. This is why technology has grown in a considerable manner in this sector. Eric Lefkofsky feels that Tempus has an advantage over companies.
He has partnered Tempus with several other prominent hospitals. They would be working together to collect enormous amounts of data. Also, Tempus has a 20,000 sq. ft. lab. This can be used for performing several gene-sequencing tests. It provides software to its physicians so that they can compare the DNA profiles of their patients with that of other cancer patients. This way it becomes easier for them to find those treatments which worked best for patients having similar genetic profiles.In 2015 Eric Lefkofsky stepped down as CEO of Groupon. This is because he wanted to focus his efforts on making Tempus a formidable company. He has hired Kevin White as he has wide experience in this industry. He has been involved in building the Institute for Genomics and Systems Biology for 10 years now.